Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT00445549 · TERMINATED

Trial details

NCT number: NCT00445549
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms

Start date: 2007-01-01
Primary completion: 2008-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.